Source: Annual Congress 2003 - Fibers and dusts
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Lehtonen, P. Oksa, L. Lehtimaki, A. Sepponen, H. Kankaanranta, S. Saarelainen, R. Jarvenpaa, J. Uitti, E. Moilanen (Tampere, Finland). Increased alveolar NO output and high condensate LTB₄ and 8-isoprostane levels in patients with asbestosis. Eur Respir J 2003; 22: Suppl. 45, 822

Member's Comments

No comment yet.

Related content which might interest you: N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005 Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Elevated TNF-α and interleukin-6 levels in breath condensate and serum of patients with non-CF bronchiectasis: comparison to COPD Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005 Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Increased IL-6 in the breath condensate of smokers Source: Eur Respir J 2002; 20: Suppl. 38, 281s Year: 2002 Increased inflammatory markers in the exhaled breath condensate of cigarette smokers Source: Eur Respir J 2003; 21: 589-593 Year: 2003 Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Increased of TNF-α Levels in breath condensate and in serum of COPD subjects Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Increased exhaled 8-isoprostane in aspirin-sensitive asthma Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Increased exhaled 8-isoprostane in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 Effect of oxygen at low flows on concentration of exhaled 8-isoprostane in healthy and COPD subjects Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005 Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 The effect of smoking on the levels of cysteinyl leukotriene in exhaled breath condensate in asthmatics Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Increased exhaled leukotrienes levels in adults with chronic cough Source: Eur Respir J 2003; 22: Suppl. 45, 475s Year: 2003